Skip to Content

Rheumatoid Arthritis – What Is New From SCR23?

During SCR23, Espen Haavardsholm, professor and president of the Scandinavian Society of Rheumatology, spoke about the current landscape with rheumatoid arthritis. In this Medtalk, he presents a few highlights from his SCR23 RA presentation, with a particular focus on the safety of JAK inhibitors and tapering medications for sustained remission.

Espen Haavardsholm

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top